A Continuation Protocol for Patients Previously Enrolled in a Study of Toca 511

Clinical trial NCT04327011 · TERMINATED

Trial details

NCT number: NCT04327011
Sponsor: Tocagen Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Glioblastoma Multiforme Astrocytoma Gliomas, Malignant

Start date: 2011-02-01
Primary completion: 2019-12-01
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.